Pricing Log in Create free account

Revelation Biosciences, Inc. (REVB) vs Silexion Therapeutics Corp (SLXN)

Revelation Biosciences, Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Revelation Biosciences, Inc. and Silexion Therapeutics Corp are of similar size ($2.2M and $2.0M). Across the 9 metrics below, Revelation Biosciences, Inc. leads on 6 and Silexion Therapeutics Corp on 3.

Valuation

Metric REVB SLXN Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.20 2.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.84 0.04 0.66
EV/Sales n/m n/m 9.02
Earnings yield (2,328.22%) (40,328.57%) (32.88%)
Free cash flow yield (466.23%) (12,933.04%) (23.13%)

Profitability

Metric REVB SLXN Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (276.43%) (17,021.95%) (51.96%)
Return on assets (214.63%) (277.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric REVB SLXN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 97.72% 97.73% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric REVB SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.21 0.94 4.97
Net debt to EBITDA 1.18 0.38 1.01

Dividend

Metric REVB SLXN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric REVB SLXN Biotechnology median
Market cap 2.02m 2.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack